[go: up one dir, main page]

PL364757A1 - Próba przesiewowa związku - Google Patents

Próba przesiewowa związku

Info

Publication number
PL364757A1
PL364757A1 PL00364757A PL36475700A PL364757A1 PL 364757 A1 PL364757 A1 PL 364757A1 PL 00364757 A PL00364757 A PL 00364757A PL 36475700 A PL36475700 A PL 36475700A PL 364757 A1 PL364757 A1 PL 364757A1
Authority
PL
Poland
Prior art keywords
screening test
compound screening
compound
test
screening
Prior art date
Application number
PL00364757A
Other languages
English (en)
Inventor
Philippe Verwaerde
Richard Feichtinger
Myriam Beghyn
Thierry Bogaert
Original Assignee
Devgen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devgen Nv filed Critical Devgen Nv
Publication of PL364757A1 publication Critical patent/PL364757A1/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/60New or modified breeds of invertebrates
    • A01K67/61Genetically modified invertebrates, e.g. transgenic or polyploid
    • A01K67/63Genetically modified worms
    • A01K67/64Genetically modified nematodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5085Supracellular entities, e.g. tissue, organisms of invertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/70Invertebrates
    • A01K2227/703Worms, e.g. Caenorhabdities elegans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G01N2333/43534Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL00364757A 1999-04-15 2000-04-14 Próba przesiewowa związku PL364757A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9908677.9A GB9908677D0 (en) 1999-04-15 1999-04-15 Compound assay
PCT/IB2000/000557 WO2000063425A2 (en) 1999-04-15 2000-04-14 Compound assay using nematodes

Publications (1)

Publication Number Publication Date
PL364757A1 true PL364757A1 (pl) 2004-12-13

Family

ID=10851619

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00364757A PL364757A1 (pl) 1999-04-15 2000-04-14 Próba przesiewowa związku

Country Status (10)

Country Link
US (2) US6664441B1 (pl)
EP (1) EP1169472A2 (pl)
JP (1) JP2002542465A (pl)
AU (1) AU3984600A (pl)
CA (1) CA2365497A1 (pl)
GB (2) GB9908677D0 (pl)
HU (1) HUP0201705A2 (pl)
MX (1) MXPA01010228A (pl)
PL (1) PL364757A1 (pl)
WO (1) WO2000063425A2 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030154501A1 (en) * 1999-04-15 2003-08-14 Devgen, N.V. Compound screening method
GB9908677D0 (en) * 1999-04-15 1999-06-09 Devgen Nv Compound assay
AUPQ436799A0 (en) * 1999-11-30 1999-12-23 Commonwealth Scientific And Industrial Research Organisation Feeding assay
DE19962263A1 (de) * 1999-12-22 2001-07-12 Elegene Gmbh Verfahren zur Feststellung neurologisch relevanter Eigenschaften eines Materials
GB9930691D0 (en) * 1999-12-24 2000-02-16 Devgen Nv Improvements relating to double-stranded RNA inhibition
GB0012229D0 (en) 2000-05-19 2000-07-12 Devgen Nv Lipid uptake assays
US7083947B2 (en) 2000-05-19 2006-08-01 Devgen Nv Assay techniques using nematode worms
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
AU2005244258B2 (en) 2004-04-09 2010-07-01 Monsanto Technology Llc Compositions and methods for control of insect infestations in plants
AR055169A1 (es) 2005-09-16 2007-08-08 Monsanto Technology Llc Metodos para el control genetico de infestaciones de insectos en plantas y composiciones para los mismos
KR100887246B1 (ko) 2007-11-22 2009-03-06 건국대학교 산학협력단 예쁜꼬마선충을 이용한 세포주기 조절인자 억제제 스크리닝방법
US9723817B2 (en) 2011-11-10 2017-08-08 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Electropharyngeogram arrays and methods of use
EP2775302A1 (en) 2013-03-08 2014-09-10 Assistance Publique - Hôpitaux de Paris Compound-carrier systems for assays in nematodes
US20150082465A1 (en) * 2013-09-13 2015-03-19 System959, LLC System and Method for Whole-Animal High-Throughput Compound Screening
CN104920307B (zh) * 2015-06-19 2018-01-26 安徽省农业科学院农业工程研究所 一种适用于单粒子微束装置的秀丽小杆线虫固定方法
CN110863030A (zh) * 2019-07-31 2020-03-06 同济大学 一种利用秀丽隐杆线虫检测发育毒性的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153599A (en) * 1979-05-18 1980-11-29 Duskin Franchise Co Ltd Toxic test method of chemical substance by using nematode
WO1990009096A2 (en) * 1989-02-03 1990-08-23 Cambridge Neuroscience Research, Inc. Method of screening and classifying compounds
US6461854B1 (en) * 1995-03-28 2002-10-08 The General Hospital Corporation Methods of screening compounds useful for prevention of infection or pathogenicity
US6329566B1 (en) * 1997-05-29 2001-12-11 The General Hospital Corporation Methods for the detection, treatment, and prevention of neurodegeneration
GB9826890D0 (en) * 1998-12-07 1999-01-27 Devgen Nv Method for screening compounds
GB9908677D0 (en) * 1999-04-15 1999-06-09 Devgen Nv Compound assay
AUPQ436799A0 (en) 1999-11-30 1999-12-23 Commonwealth Scientific And Industrial Research Organisation Feeding assay

Also Published As

Publication number Publication date
AU3984600A (en) 2000-11-02
GB0009360D0 (en) 2000-05-31
GB2351152B (en) 2001-07-25
HUP0201705A2 (en) 2002-09-28
EP1169472A2 (en) 2002-01-09
US6664441B1 (en) 2003-12-16
HK1030652A1 (en) 2001-05-11
MXPA01010228A (es) 2002-04-09
GB9908677D0 (en) 1999-06-09
WO2000063425A3 (en) 2001-03-08
GB2351152A (en) 2000-12-20
JP2002542465A (ja) 2002-12-10
WO2000063425A2 (en) 2000-10-26
CA2365497A1 (en) 2000-10-26
US7030290B2 (en) 2006-04-18
US20040034880A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
DE69929895D1 (de) Prüfvorrichtung
DE60036746D1 (de) Analysator
DE19900833B4 (de) Testhalterung
DE50015294D1 (de) Mikrotom
DE60023211D1 (de) Materialprüfung
EP1146501A4 (en) DISPLAY
NO20016115L (no) Substituerte heterosykelkondenserte gamma-karbolin
PT1224180E (pt) Azois substituidos
DE60001597D1 (de) Spannvorrichtung
DE19983311T1 (de) Siebvorrichtung
EE200100502A (et) Ühendid
DE60039482D1 (de) Spannvorrichtung
DE60038335D1 (de) Spannvorrichtung
DE60026345D1 (de) Siebeinrichtung
FI991134L (fi) Ohjelmiston testaus
DE60038329D1 (de) Spannvorrichtung
PL364757A1 (pl) Próba przesiewowa związku
DE60024044D1 (de) Reibungstestgerät
FI991268L (fi) Lähetin-vastaanottimen testaus
NO20013769L (no) Kalsilytiske forbindelser
DE69814344D1 (de) Siebvorrichtung
DE69941322D1 (de) Verbindungstestverfahren
NO20020466D0 (no) Kalsilytiske forbindelser
ID28840A (id) Pengujian
DE59907833D1 (de) Siebeinrichtung

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)